Literature DB >> 11532558

Protean infectious types and frequent association with neurosurgical procedures in adult Serratia marcescens CNS infections: report of two cases and review of the literature.

C R Huang1, C H Lu, C C Chien, W N Chang.   

Abstract

Serratia marcescens is a rare pathogen of adult central nervous system (CNS) infection. We report on the clinical features and therapeutic outcomes of two adult patients with such infections. The clinical characteristics of 13 other reported adult cases are also included for analysis. The 15 cases were nine males and six females, aged 19-83 years, in whom, underlying post-neurosurgical states and ear operation were noted in 93% (14/15). Fever and conscious disturbance were the most common clinical manifestations of these 15 cases, followed by hydrocephalus, seizures, and wound infections. The manifestation types were protean, including meningitis and focal suppurations such as brain abscess, cranial and spinal epidural abscess, cranial subdural abscess, and infected lumbar pseudomeningocele. One case of S. marcescens CNS infection was diagnosed postmortem; the other 14 were diagnosed by the positive culture from CSF or pus. Antibiotic therapy with or without neurosurgical intervention was the management strategy in 14/15 cases. The therapeutic results showed a high mortality rate.

Entities:  

Mesh:

Year:  2001        PMID: 11532558     DOI: 10.1016/s0303-8467(01)00138-x

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  2 in total

1.  Community-acquired Serratia marcescens spinal epidural abscess in a patient without risk factors: Case report and review.

Authors:  Michael D Parkins; Daniel B Gregson
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-05       Impact factor: 2.471

Review 2.  Serratia Liver Abscess Infection and Cardiomyopathy in a Patient with Diabetes Mellitus: A Case Report and Review of the Literature.

Authors:  Anna Sarah Erem; Anna Krapivina; Timothy S Braverman; Shyam S Allamaneni
Journal:  Am J Case Rep       Date:  2019-09-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.